Multivesicular liposomal bupivacaine at the sciatic nerve
- 1 May 2014
- journal article
- Published by Elsevier in Biomaterials
- Vol. 35 (15) , 4557-4564
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Extended pain relief trial utilizing infiltration of Exparel®, a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomyJournal of Pain Research, 2012
- Toxicogenomic analysis of a sustained release local anesthetic delivery systemBiomaterials, 2012
- The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and DogsJournal of Drug Delivery, 2012
- Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature PigsISRN Pharmaceutics, 2011
- Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species ComparisonJournal of Drug Delivery, 2011
- A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomyAdvances in Therapy, 2011
- Biocompatibility and drug delivery systemsChemical Science, 2010
- Prolonged duration local anesthesia with minimal toxicityProceedings of the National Academy of Sciences, 2009
- Ultra‐Long‐Duration Local Anesthesia Produced by Injection of Lecithin‐Coated Tetracaine MicrocrystalsThe Journal of Clinical Pharmacology, 1994
- Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine.Chemical and Pharmaceutical Bulletin, 1982